Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03487315
Other study ID # 842/2559(EC3)
Secondary ID
Status Completed
Phase N/A
First received August 31, 2017
Last updated March 27, 2018
Start date April 5, 2017
Est. completion date March 5, 2018

Study information

Verified date March 2018
Source Mahidol University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

- To study Major allergen in Wheat anaphylaxis in Thai population

- To study and compare demographic data between group of wheat anaphylaxis


Description:

Wheat is one of the most common causes in food-induced anaphylaxis and food dependent, exercised induced anaphylaxis. Gold standard for diagnose food allergy is double blind placebo control food challenge, but it is a high risk procedure. The accuracy of skin prick test and specific IgE assay showed unsatisfactory results. It might be explained by these tests may not detect all of the major allergens in wheat allergic patients. Previous studies showed that the major allergens of wheat dependent, exercised induced anaphylaxis are omega5 gliadin, followed by high molecular weight glutenin. For IgE-mediated wheat allergy, the major allergens varied among studies, including omega5 gliadin, glutenin, alpha/beta/gamma gliadin, and the water-soluble part of wheat allergens. There is no study to direct compare the major allergen between patients who have low wheat specific IgE and very high wheat specific IgE. Also, there is no data about the major allergens of wheat anaphylaxis in Thai population.


Recruitment information / eligibility

Status Completed
Enrollment 36
Est. completion date March 5, 2018
Est. primary completion date March 5, 2018
Accepts healthy volunteers No
Gender All
Age group 1 Year to 60 Years
Eligibility Inclusion Criteria:

- Wheat anaphylaxis patient aged 1-60 years, who received treatment at division of allergy, department of Pediatrics and Medicine, Siriraj Hospital from 2001 to 2016

Exclusion Criteria:

- Loss follow up

- No consent form

- Celiac disease, Autoimmune disease was diagnosed

Study Design


Intervention

Diagnostic Test:
immunoblot
immunoblot

Locations

Country Name City State
Thailand Siriraj Hospital Bangkok Noi Bangkok

Sponsors (1)

Lead Sponsor Collaborator
Mahidol University

Country where clinical trial is conducted

Thailand, 

References & Publications (1)

Nilsson N, Sjölander S, Baar A, Berthold M, Pahr S, Vrtala S, Valenta R, Morita E, Hedlin G, Borres MP, Nilsson C. Wheat allergy in children evaluated with challenge and IgE antibodies to wheat components. Pediatr Allergy Immunol. 2015 Mar;26(2):119-25. d — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Major allergen sensitized by Thai Patients with Wheat anaphylaxis To Identify major allergen (most component of protein that cause wheat allergy) between wheat anaphylaxis (low Specific IgE and high Specific IgE) and wheat dependent, exercise induced anaphylaxis by using immunoblot method (Electrophoresis). The results will be shown in electrophoresis gel and can identify in molecular weight (KDa) of protein which represent to major allergen of wheat protein. 1 hour
See also
  Status Clinical Trial Phase
Completed NCT04100122 - Luminex-based Assay to Identify Major IgE-binding Episode Among IgE-mediated Wheat-allergic Patient
Completed NCT01980992 - Oral Immunotherapy for Wheat Allergy Phase 1/Phase 2
Terminated NCT02341040 - Evaluation of Potential Allergenicity of New Wheat Varieties
Completed NCT01801748 - The Natural History of Wheat Hypersensitivity in Thai Children N/A
Recruiting NCT06069492 - Randomized Controlled Trial for Wheat Oral Immunotherapy N/A
Completed NCT01070368 - Accuracy Of Skin Prick Test Using In-house Wheat Extract For The Diagnosis Of IgE-mediated Wheat Allergy: A Pilot Study N/A
Terminated NCT04013763 - Outcome of Specific IgE Level in Children With IgE-mediated Wheat Allergy After Stop Using Wheat Containing Skin Care N/A
Recruiting NCT03352193 - Specific Oral Tolerance Induction (SOTI) to Children With IgE-mediated Wheat Allergy
Completed NCT01755884 - Oral Desensitization to Wheat in School Aged Children N/A